Le Lézard
Classified in: Health, Covid-19 virus
Subjects: PDT, CSR, FDA, MAT

Savage Enterprises Leads the Way as an Accepted Hand Sanitizer Manufacturer With FDA


IRVINE, Calif., March 30, 2020 /PRNewswire/ -- In response to the current global pandemic, COVID-19, Savage Enterprises is pleased to announce the newest product to join the Savage Essentials family, Savage Hand Sanitizer.

As many industry leaders rush to aid the country because of the lack of personal protective equipment, Savage has converted a substantial portion of its State of the Art facility to be able to manufacture and cleanly produce high-quality hand sanitizer capable of destroying 99% of germs.

Savage Enterprises contracted Vape Rescue compliance solutions to assist with registering the sanitizer with the FDA. On March 30, 2020, Savage Enterprises is pleased to report the completion of the registration process and acceptance by the FDA. Thus making Savage one of the first Liquid Manufacturers to successfully introduce an OTC product onto the market.

Savage Enterprises will be donating large quantities to local health departments, hospitals, and medical personal to help keep our public health workers safe during these trying times. It will be available via website for retail, wholesale and in hundreds of great retail outlets across the country.

Savage Essentials Hand Sanitizer will be available in 2oz bottle sizes, comprised of glycol, 75% isopropyl alcohol and aloe.

Press Contact

Brittany G Warner
[email protected]

Related Images

savage-hand-sanitizer.jpg
Savage Hand Sanitizer

SOURCE Savage Enterprises


These press releases may also interest you

at 00:25
Shanghai Junshi Biosciences Co., Ltd ("Junshi Biosciences," HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies, announced its financial...

28 mar 2024
The report titled "Central Lab Market by Service Type (Anatomic Pathology/Histology, Biomarker Services, Genetic Services), Phase (Phase 1, Phase 2, Phase 3), Therapeutic Area, End-use - Global Forecast 2024-2030" is now available on...

28 mar 2024
The report titled "Personalized Nutrition Market by Measurement Type (Active Measurement, Standard Measurement), Application (Indication-based, Standard Supplements), Distribution Channel, End-Use - Global Forecast 2024-2030" is now available on...

28 mar 2024
The report titled "Carbon Dioxide Incubator Market by Product (Air Jacketed CO2 Incubators, Direct Heat CO2 Incubators, Water Jacketed CO2 Incubators), Capacity (100-200 Litre, Above 200 Litre, Below 100 Litre), Application, End User - Global...

28 mar 2024
The "Global Clinical In Vitro Diagnostic Medical Laboratory Services Market: Strategy & Trends with Volume & Price Forecasts by Chemistry, Hematology, Microbiology, Pathology, Covid-19, and Molecular Dx by Country. Updated with Impact of COVID-19"...

28 mar 2024
The "Molecular Diagnostics at the Point of Care. By Application, Technology, Place, Product and by Country. With Executive Guides and Customization 2023 - 2027 " report has been added to  ResearchAndMarkets.com's offering. Infectious disease Dx is...



News published on and distributed by: